The performance of HCV GT plus RUO reagent in determining Hepatitis C virus genotypes in Taiwan

por Huang, Ying-Chou, Huang, Chung-Feng, Liu, Shu-Fen, Liu, Hung-Yin, Yeh, Ming-Lun, Huang, Ching-I, Hsieh, Meng-Hsuan, Dai, Chia-Yen, Chen, Shinn-Chern, Yu, Ming-Lung, Chuang, Wan-Long, Huang, Jee-Fu
Publicado 2021

Scaling up the in-hospital hepatitis C virus care cascade in Taiwan

por Huang, Chung-Feng, Wu, Pey-Fang, Yeh, Ming-Lun, Huang, Ching-I, Liang, Po-Cheng, Hsu, Cheng-Ting, Hsu, Po-Yao, Liu, Hung-Yin, Huang, Ying-Chou, Lin, Zu-Yau, Chen, Shinn-Cherng, Huang, Jee-Fu, Dai, Chia-Yen, Chuang, Wan-Long, Yu, Ming-Lung
Publicado 2021

Anti-HCV antibody titer highly predicts HCV viremia in patients with hepatitis B virus dual-infection

por Liu, Hung-Yin, Lin, Yi-Hung, Lin, Pei-Ju, Tsai, Pei-Chien, Liu, Shu-Fen, Huang, Ying-Chou, Tsai, Jia-Jiun, Huang, Ching-I, Yeh, Ming-Lun, Liang, Po-Cheng, Lin, Zu-Yau, Dai, Chia-Yen, Huang, Jee-Fu, Chuang, Wan-Long, Huang, Chung-Feng, Yu, Ming-Lung
Publicado 2021